# Development of a Rapid Diagnostic Test to Distinguish between Emerging Viruses That Cause Hemorrhagic Fever

**Authors:** Andrew Wilson, Heather Poeck-Goux, Madison Ruschaupt, Scott Olschner, Keersten M. Ricks, Darci R. Smith

PMC · DOI: 10.4269/ajtmh.25-0168 · The American Journal of Tropical Medicine and Hygiene · 2025-09-18

## TL;DR

Researchers developed a rapid diagnostic test to distinguish between viruses that cause hemorrhagic fever, using improved antibody labeling methods for better performance.

## Contribution

The study introduces a novel rapid diagnostic test using cellulose nanobeads to detect multiple hemorrhagic fever viruses simultaneously.

## Key findings

- Cellulose nanobeads improved performance for detecting dengue, yellow fever, Rift Valley fever, and orthomarburgviruses.
- An eight-plex cartridge was successfully developed for simultaneous detection of seven viruses.
- Multiplex assays were less sensitive than single-plex assays, but the single-plex CNB assays showed high specificity.

## Abstract

Viruses that cause the clinical syndrome referred to as viral hemorrhagic fever (VHF) are responsible for numerous infectious disease outbreaks. High-priority emerging viruses include orthoebolaviruses, orthomarburgviruses, Lassa virus, Crimean–Congo hemorrhagic fever virus, Rift Valley fever virus (RVFV), dengue virus (DENV), and yellow fever virus (YFV). Many of these viruses cause a similar clinical presentation in infected humans and have an overlapping geographic distribution with a risk of coemergence. As such, an antigen rapid diagnostic test to distinguish between these viruses would be beneficial in low-resource settings. In this study, we developed single-plex and multiplex antigen detection lateral flow immunoassays (LFIs) to rapidly detect and distinguish between emerging viruses that can cause VHF. We evaluated two antibody-labeling methods, colloidal gold nanoparticles and cellulose nanobeads (CNBs), to determine which approach would increase assay performance and multiplexing capabilities. Assay performance was evaluated by determining their sensitivity, specificity, matrix evaluation, and stability testing. All assays were highly specific, with no crossreactivity observed for the single-plex assays. Several of the assays performed better with the CNBs, including the DENV, YFV, RVFV, and orthomarburgvirus LFIs. No matrix effect was observed with most of the assays except that serum did impact the RVFV and DENV assays. In general, the multiplex assays were less sensitive compared with their respective single-plex assay. The most successful assays were the single-plex CNB LFIs assembled into an eight-plex cartridge, which allows for rapid and simultaneous testing of antigen to seven viruses.

## Linked entities

- **Diseases:** viral hemorrhagic fever (MONDO:0018087), dengue (MONDO:0005502), yellow fever (MONDO:0020502), Rift Valley fever (MONDO:0017880)

## Full-text entities

- **Diseases:** VHF (MESH:D006482), infectious disease (MESH:D003141), infected (MESH:D007239), Crimean-Congo hemorrhagic fever virus (MESH:D006479), Hemorrhagic Fever (MESH:D006480)
- **Chemicals:** gold (MESH:D006046)
- **Species:** Homo sapiens (human, species) [taxon 9606], Dengue virus (no rank) [taxon 12637], Rift Valley fever virus (no rank) [taxon 11588], Lassa virus [taxon 11620], Yellow fever virus (no rank) [taxon 11089]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12590983/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12590983/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12590983/full.md

---
Source: https://tomesphere.com/paper/PMC12590983